Harel Insurance Investments & Financial Services’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,598
Closed -$3K 469
2025
Q2
$3K Hold
1,598
﹤0.01% 420
2025
Q1
$2K Hold
1,598
﹤0.01% 474
2024
Q4
$2K Hold
1,598
﹤0.01% 463
2024
Q3
$3K Hold
1,598
﹤0.01% 483
2024
Q2
$3K Hold
1,598
﹤0.01% 525
2024
Q1
$4K Hold
1,598
﹤0.01% 517
2023
Q4
$3K Hold
1,598
﹤0.01% 581
2023
Q3
$1K Hold
1,598
﹤0.01% 646
2023
Q2
$2K Hold
1,598
﹤0.01% 675
2023
Q1
$1K Hold
1,598
﹤0.01% 693
2022
Q4
$1K Hold
1,598
﹤0.01% 673
2022
Q3
$1K Hold
1,598
﹤0.01% 691
2022
Q2
$3K Hold
1,598
﹤0.01% 692
2022
Q1
$5K Hold
1,598
﹤0.01% 668
2021
Q4
$7K Buy
+1,598
New +$8.64K ﹤0.01% 694
2020
Q3
Sell
-9,000
Closed -$135K 634
2020
Q2
$135K Buy
+9,000
New +$121K ﹤0.01% 298
2018
Q1
Sell
-952,346
Closed -$2.38M 452
2017
Q4
$2.38M Buy
+952,346
New +$2.83M 0.15% 66

Other funds holding CGEN

Harel Insurance Investments & Financial Services's CGEN Position: Q3 2025 in Review

Harel Insurance Investments & Financial Services sold out of Compugen (CGEN) in Q3 2025, closing a stake of 1,598 shares — an estimated $3K sold.

Harel Insurance Investments & Financial Services first reported a position in CGEN in Q4 2017 and held it in 17 quarters. The position peaked at $2.38M in Q4 2017. 69 funds tracked by Wall St. Rank hold CGEN as of Q3 2025.

  • Harel Insurance Investments & Financial Services reported no remaining Compugen position as of Q3 2025 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,598 Compugen shares in Q3 2025, an estimated $3K.
  • Harel Insurance Investments & Financial Services first reported a position in Compugen in Q4 2017 and held it in 17 quarters.
  • Harel Insurance Investments & Financial Services's Compugen position peaked at $2.38M in Q4 2017.
  • 69 funds tracked by Wall St. Rank held Compugen as of Q3 2025.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2025, filed 29 Oct 2025.